Form 483

ActiveHerb Technology, Inc Form 483, 2021-08-06

FDA issued a Form 483 to ActiveHerb Technology, Inc on 2021-08-06 with 12 public-safe observations.

483· Form 483 issuedFoods & Cosmetics12 observations

ActiveHerb Technology, Inc · San Diego, United States · Issued August 6, 2021

Overview

  • 12 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Aug 2021
21 CFR 111.113(a)(5)

QC returned dietary supplement; material review, disposition

Cited by Amanda N Schaupp, Natalie Rodriguez

6 Aug 2021
21 CFR 111.113(a)(5)

QC returned dietary supplement; material review, disposition

Cited by Amanda N Schaupp, Natalie Rodriguez

6 Aug 2021
21 CFR 111.127(e)

QC ops packaging, labeling; material review, disposition

Cited by Amanda N Schaupp, Natalie Rodriguez

6 Aug 2021
21 CFR 111.127(e)

QC ops packaging, labeling; material review, disposition

Cited by Amanda N Schaupp, Natalie Rodriguez

6 Aug 2021
21 CFR 111.70(b)(1)

Specifications - component identity

Cited by Amanda N Schaupp, Natalie Rodriguez

Inspected site

ATActiveHerb Technology, IncSan Diego, United States

Inspection team

NRNatalie Rodriguez

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.113(a)(5)Cited across public-safe Form 483 observations2x
21 CFR 111.127(e)Cited across public-safe Form 483 observations2x
21 CFR 111.70(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.70(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 111.70(e)Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(2)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 12 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere